Translation of <scp>IDEA</scp> trial results into clinical practice: Analysis of the implementation of a new guideline for colon cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Translation of IDEA trial results into clinical practice: Analysis of the implementation of a new guideline for colon cancer

Published:2022-06-21 Issue:8 Volume:151 Page:1270-1279
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Intl Journal of Cancer

Author:

van Rooijen Karlijn L.¹²^ORCID,Derksen Jeroen W. G.³,Verkooijen Helena M.³,Vink Geraldine R.¹⁴,Koopman Miriam¹^ORCID

Affiliation:

1. Department of Medical Oncology University Medical Center Utrecht, Utrecht University Utrecht The Netherlands

2. Department of Internal Medicine Hospital St. Jansdal Harderwijk The Netherlands

3. Julius Center for Health Sciences and Primary Care University Medical Center Utrecht, Utrecht University Utrecht The Netherlands

4. Department of Research and Development Netherlands Comprehensive Cancer Organisation Utrecht The Netherlands

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.34149

Reference38 articles.

1. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study

2. Oxaliplatin Combined With Weekly Bolus Fluorouracil and Leucovorin As Surgical Adjuvant Chemotherapy for Stage II and III Colon Cancer: Results From NSABP C-07

3. Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer

4. Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma

5. Phase III Study of Fluorouracil, Leucovorin, and Levamisole in High-Risk Stage II and III Colon Cancer: Final Report of Intergroup 0089

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival and patient-reported outcomes of real-world high-risk stage II and stage III colon cancer patients after reduction of adjuvant CAPOX duration from 6 to 3 months;European Journal of Cancer;2024-09

2. Harnessing the Potential of Real-World Evidence in the Treatment of Colorectal Cancer: Where Do We Stand?;Current Treatment Options in Oncology;2024-02-17

3. Early evaluation of the effectiveness and cost-effectiveness of ctDNA-guided selection for adjuvant chemotherapy in stage II colon cancer;Therapeutic Advances in Medical Oncology;2024-01

4. Trends and Prescriber Variation in the Duration of Oxaliplatin-Containing Adjuvant Chemotherapy for Stage III Colon Cancer From 2007 to 2019: A Population-Based Retrospective Cohort Study;Clinical Colorectal Cancer;2023-12

5. The diagnostic accuracy of local staging in colon cancer based on computed tomography (CT): evaluating the role of extramural venous invasion and tumour deposits;Abdominal Radiology;2023-11-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3